StonvexLoading…
StonvexStonvexStonvexCore line items from OFLX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $98.30M | $101.68M | $111.47M | $125.49M |
Operating Income | $16.93M | $21.57M | $25.80M | $31.02M |
Net Income | $14.83M | $18.01M | $20.76M | $23.62M |
EPS (Diluted) | $1.47 | $1.78 | $2.06 | $2.34 |
Total Assets | $104.95M | $105.89M | $100.23M | $97.68M |
Total Liabilities | $20.95M | $22.71M | $21.38M | $26.51M |
Cash & Equivalents | $53.23M | $51.70M | $46.36M | $37.70M |
Free Cash Flow OCF − CapEx | $15.35M | $18.85M | $21.78M | $14.30M |
Shares Outstanding | 10.09M | 10.09M | 10.09M | 10.09M |